SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-050307
Filing Date
2021-04-14
Accepted
2021-04-14 17:28:01
Documents
48
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2112635d1_10q.htm 10-Q 337486
2 EXHIBIT 31.1 tm2112635d1_ex31-1.htm EX-31.1 12507
3 EXHIBIT 32.1 tm2112635d1_ex32-1.htm EX-32.1 5075
  Complete submission text file 0001104659-21-050307.txt   2873036

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20210228.xml EX-101.INS 626796
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20210228.xsd EX-101.SCH 30460
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20210228_cal.xml EX-101.CAL 27500
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20210228_def.xml EX-101.DEF 119303
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20210228_lab.xml EX-101.LAB 255004
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20210228_pre.xml EX-101.PRE 204164
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 21826556
SIC: 2834 Pharmaceutical Preparations